88 related articles for article (PubMed ID: 8721821)
1. [The clenbuterol treatment of patients with the chronic obstructive syndrome].
Ionescu AA; Bistriceanu G; Bogdan M; Duţu S
Pneumoftiziologia; 1995; 44(1-2):45-7. PubMed ID: 8721821
[TBL] [Abstract][Full Text] [Related]
2. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
Baronti A; Grieco A; Vibelli C
Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
4. [New developments in the field of bronchospasmolytics].
Nolte D
Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306
[No Abstract] [Full Text] [Related]
5. Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.
Tschan M; Perruchoud A; Herzog H
Eur J Clin Pharmacol; 1979 Apr; 15(3):159-62. PubMed ID: 378670
[TBL] [Abstract][Full Text] [Related]
6. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
Anthonisen NR; Connett JE; Kiley JP; Altose MD; Bailey WC; Buist AS; Conway WA; Enright PL; Kanner RE; O'Hara P
JAMA; 1994 Nov; 272(19):1497-505. PubMed ID: 7966841
[TBL] [Abstract][Full Text] [Related]
7. [Influencing respiratory gas analytical lung function parameters by intravenous injection of clenbuterol in horses with chronic lung diseases].
Sander K; Deegen E; Ohnesorge B
Dtsch Tierarztl Wochenschr; 2002 Jul; 109(7):295-9. PubMed ID: 12161967
[TBL] [Abstract][Full Text] [Related]
8. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
Anastasatu C; Duţu S
Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
[No Abstract] [Full Text] [Related]
9. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
Boner AL; Sette L; Castellani C; Schiassi M
J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
[TBL] [Abstract][Full Text] [Related]
10. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
Jaffé G; Grimshaw JJ
Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on the oral therapy of obstructive respiratory tract diseases with clenbuterol, fenoterol and depot-orciprenaline (double-blind study)].
Flohr E; Bischoff KO
Verh Dtsch Ges Inn Med; 1978; (84):417-20. PubMed ID: 369198
[No Abstract] [Full Text] [Related]
12. Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).
Brusasco V; Vibelli C; Chierichetti S; Ramoino R
Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):589-93. PubMed ID: 365800
[TBL] [Abstract][Full Text] [Related]
13. Effect of clenbuterol on peripheral airway obstruction in bronchial asthma.
Hida W; Sakurai M; Ichinose M; Shindoh C; Chonan T; Kikuchi Y; Inoue H; Takishima T
Curr Med Res Opin; 1985; 9(9):616-25. PubMed ID: 3902376
[TBL] [Abstract][Full Text] [Related]
14. [Role of bronchospasm in development of bronchial obstruction in chronic bronchitis].
Nefedov VB; Shergina EA
Ter Arkh; 2000; 72(11):57-9. PubMed ID: 11229314
[TBL] [Abstract][Full Text] [Related]
15. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
Ulmer WT; Scholz HJ; Baines A
Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
[TBL] [Abstract][Full Text] [Related]
16. Effect of an aerosol delivery system on bronchodilator activity.
Crimi N; Palermo F; Cacopardo B; Vancheri C; Oliveri R; Polosa R; Mistretta A
Ann Allergy; 1989 Jan; 62(1):26-9. PubMed ID: 2912322
[TBL] [Abstract][Full Text] [Related]
17. Intratracheal clenbuterol in the horse: its pharmacological efficacy and analytical detection.
Harkins JD; Robinson NE; Woods WE; Lehner AF; Smith MD; Gates RS; Fisher M; Tobin T
J Vet Pharmacol Ther; 2000 Aug; 23(4):251-60. PubMed ID: 11106998
[TBL] [Abstract][Full Text] [Related]
18. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.
Tweeddale PM; Alexander F; McHardy GJ
Thorax; 1987 Jul; 42(7):487-90. PubMed ID: 3438892
[TBL] [Abstract][Full Text] [Related]
19. [Bronchospasmolysis with Atroven (SCH 1.000) (author's transl)].
Sill V; Voelkel N; Lanser K; Marwede S
MMW Munch Med Wochenschr; 1976 Feb; 118(6):177-80. PubMed ID: 815800
[TBL] [Abstract][Full Text] [Related]
20. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy.
Fujimura M; Kamio Y; Hashimoto T; Matsuda T
J Asthma; 1994; 31(6):463-72. PubMed ID: 7961323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
